Fredericks S et al. |
Multidrug resistance gene-1 (MDR-1) haplotypes have a minor influence on tacrolimus dose requirements. |
2006 |
Transplantation |
pmid:16969296
|
Gralla J and Wiseman AC |
Tacrolimus/sirolimus versus tacrolimus/mycophenolate in kidney transplantation: improved 3-year graft and patient survival in recent era. |
2009 |
Transplantation |
pmid:19502965
|
Morrissey PE |
Prope tolerance: is it the end or the means? |
2009 |
Transplantation |
pmid:19502973
|
Farid SG et al. |
Alemtuzumab (Campath-1H)-induced coagulopathy in renal transplantation. |
2009 |
Transplantation |
pmid:19502974
|
Garcia-Criado FJ et al. |
Tacrolimus (FK506) down-regulates free radical tissue levels, serum cytokines, and neutrophil infiltration after severe liver ischemia. |
1997 |
Transplantation |
pmid:9293871
|
Suzuki H et al. |
Induction of transplantation tolerance in adult rats by vascularized spleen transplantation. |
1997 |
Transplantation |
pmid:9293881
|
Alloway RR |
Mounting Clinical Evidence With Tacrolimus Generic Products. |
2017 |
Transplantation |
pmid:28749820
|
First MR |
Transplantation in the nineties. |
1992 |
Transplantation |
pmid:1370734
|
Satterthwaite R et al. |
Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine. |
1998 |
Transplantation |
pmid:9484771
|
Prókai à et al. |
Calcineurin-inhibition Results in Upregulation of Local Renin and Subsequent Vascular Endothelial Growth Factor Production in Renal Collecting Ducts. |
2016 |
Transplantation |
pmid:26502369
|
Lee D et al. |
Age and Early Graft Function Relate With Risk-Benefit Ratio of Allogenic Islet Transplantation Under Antithymocyte Globulin-Mycophenolate Mofetil-Tacrolimus Immune Suppression. |
2017 |
Transplantation |
pmid:27779572
|
Wozniak LJ et al. |
Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation. |
2015 |
Transplantation |
pmid:26038872
|
Kuypers DR et al. |
Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: the need for true drug exposure measurements. |
2010 |
Transplantation |
pmid:20555228
|
Yang CW et al. |
Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney. |
2001 |
Transplantation |
pmid:11740384
|
Sheikh AM et al. |
Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels. |
1999 |
Transplantation |
pmid:10440408
|
Moxey-Mims MM |
Increased incidence of insulin-dependent diabetes mellitus in pediatric renal transplant patients receiving tacrolimus (FK506) |
1999 |
Transplantation |
pmid:10440413
|
Guethoff S et al. |
Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation. |
2013 |
Transplantation |
pmid:23423270
|
Miyakoshi S et al. |
Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases. |
2007 |
Transplantation |
pmid:17700155
|
Johnson MC et al. |
QT prolongation and Torsades de Pointes after administration of FK506. |
1992 |
Transplantation |
pmid:1373538
|
Naesens M et al. |
The impact of renal allograft function on exposure and elimination of mycophenolic acid (MPA) and its metabolite MPA 7-O-glucuronide. |
2007 |
Transplantation |
pmid:17700162
|
Kim YI et al. |
Stimulation of liver regeneration by pretreatment with azathioprine as well as cyclosporine and FK506. |
1992 |
Transplantation |
pmid:1373539
|
Pratschke J et al. |
Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation. |
1997 |
Transplantation |
pmid:9326428
|
McGhee B et al. |
Therapeutic use of an extemporaneously prepared oral suspension of tacrolimus in pediatric patients. |
1997 |
Transplantation |
pmid:9326429
|
Huang E et al. |
Alemtuzumab induction in deceased donor kidney transplantation. |
2007 |
Transplantation |
pmid:17984833
|
Kato T et al. |
Randomized trial of steroid-free induction versus corticosteroid maintenance among orthotopic liver transplant recipients with hepatitis C virus: impact on hepatic fibrosis progression at one year. |
2007 |
Transplantation |
pmid:17984834
|
Tuteja S et al. |
The effect of gut metabolism on tacrolimus bioavailability in renal transplant recipients. |
2001 |
Transplantation |
pmid:11397967
|
Kahan BD |
An immunosuppressive triumvirate to minimize renal injuries associated with calcineurin antagonist therapy. |
1999 |
Transplantation |
pmid:10428260
|
Washburn K et al. |
Steroid elimination 24 hours after liver transplantation using daclizumab, tacrolimus, and mycophenolate mofetil. |
2001 |
Transplantation |
pmid:11726831
|
Reichenspurner H et al. |
Optimization of the immunosuppressive protocol after lung transplantation. |
1999 |
Transplantation |
pmid:10428269
|
Pilmore HL et al. |
Tacrolimus for the treatment of gout in renal transplantation: two case reports and review of the literature. |
2001 |
Transplantation |
pmid:11726837
|
Soccal PM et al. |
Improvement of drug-induced chronic renal failure in lung transplantation. |
1999 |
Transplantation |
pmid:10428288
|
Muthukumar T et al. |
HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: clinical outcomes and messenger RNA profiles. |
2013 |
Transplantation |
pmid:23503504
|
Lee CM et al. |
Outcomes in diabetic patients after simultaneous pancreas-kidney versus kidney alone transplantation. |
1997 |
Transplantation |
pmid:9371670
|
Migita K et al. |
FK506 potentiates steroid-induced T-cell apoptosis. |
1997 |
Transplantation |
pmid:9371682
|
Hricik DE et al. |
Long-term graft outcomes after steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus. |
2007 |
Transplantation |
pmid:17297401
|
Sharif A et al. |
Insulin resistance indexes in renal transplant recipients maintained on tacrolimus immunosuppression. |
2010 |
Transplantation |
pmid:20145524
|
Shapiro R et al. |
Pediatric renal transplantation under tacrolimus-based immunosuppression. |
1999 |
Transplantation |
pmid:10075598
|
Abu-Qaoud MS et al. |
Lack of relationship between microvascular and macrovascular disease in heart transplant recipients. |
2012 |
Transplantation |
pmid:23044666
|
Kaplan B et al. |
Low bioavailability of cyclosporine microemulsion and tacrolimus in a small bowel transplant recipient: possible relationship to intestinal P-glycoprotein activity. |
1999 |
Transplantation |
pmid:10075604
|
Mueller AR et al. |
Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506. |
1994 |
Transplantation |
pmid:7518974
|
Hirano Y et al. |
The effects of FK506 and cyclosporine on the exocrine function of the rat pancreas. |
1992 |
Transplantation |
pmid:1279850
|
Takaya S et al. |
Liver transplantation in positive cytotoxic crossmatch cases using FK506, high-dose steroids, and prostaglandin E1. |
1992 |
Transplantation |
pmid:1279851
|
Ciancio G et al. |
Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplantation with tacrolimus and steroid avoidance: four-year analysis. |
2011 |
Transplantation |
pmid:21107305
|
Wasik M et al. |
Effect of FK506 versus cyclosporine on human natural and antibody-dependent cytotoxicity reactions in vitro. |
1991 |
Transplantation |
pmid:1702910
|
Carroll PB et al. |
Effect of the immunosuppressant FK506 on glucose-induced insulin secretion from adult rat islets of Langerhans. |
1991 |
Transplantation |
pmid:1702911
|
Woodward RS et al. |
Renal graft survival and calcineurin inhibitor. |
2005 |
Transplantation |
pmid:16177637
|
Merkle M et al. |
The effect of sevelamer on tacrolimus target levels. |
2005 |
Transplantation |
pmid:16177649
|
Jain A et al. |
Conversion to neoral for neurotoxicity after primary adult liver transplantation under tacrolimus. |
2000 |
Transplantation |
pmid:10653398
|
Textor SC et al. |
Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients. |
1993 |
Transplantation |
pmid:7685934
|
Arzouk N et al. |
Interaction between tacrolimus and fumagillin in two kidney transplant recipients. |
2006 |
Transplantation |
pmid:16421493
|
Kandula P et al. |
Impact of tacrolimus-sirolimus maintenance immunosuppression on proteinuria and kidney function in pancreas transplant alone recipients. |
2012 |
Transplantation |
pmid:23037007
|
Vennarecci G et al. |
Apoptosis and rejection in rat intestinal transplantation: correlation with FK506 doses and donor specific bone marrow infusions. |
2001 |
Transplantation |
pmid:11455248
|
First MR et al. |
New-onset diabetes after transplantation (NODAT): an evaluation of definitions in clinical trials. |
2013 |
Transplantation |
pmid:23619735
|
Schulman SL et al. |
Interaction between tacrolimus and chloramphenicol in a renal transplant recipient. |
1998 |
Transplantation |
pmid:9625026
|
Tanaka M et al. |
Effect of anticomplement agent K76 COOH on hamster-to-rat and guinea pig-to-rat heart xenotransplantation. |
1996 |
Transplantation |
pmid:8830837
|
Opelz G |
Comparison of FK506 and cyclosporine. |
1996 |
Transplantation |
pmid:8830844
|
Yoshimura N et al. |
Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity. |
1989 |
Transplantation |
pmid:2465592
|
Yoshimura N et al. |
Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. II. Inhibition of the production of IL-2 and gamma-IFN, but not B cell-stimulating factor 2. |
1989 |
Transplantation |
pmid:2465593
|
Ninova D et al. |
Acute nephrotoxicity of tacrolimus and sirolimus in renal isografts: differential intragraft expression of transforming growth factor-beta1 and alpha-smooth muscle actin. |
2004 |
Transplantation |
pmid:15316360
|
Ciancio G et al. |
The use of Campath-1H as induction therapy in renal transplantation: preliminary results. |
2004 |
Transplantation |
pmid:15316372
|
Uemura T et al. |
Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation. |
2011 |
Transplantation |
pmid:21841541
|
Berg UB et al. |
Renal function before and long after liver transplantation in children. |
2001 |
Transplantation |
pmid:11544422
|
Aw MM et al. |
Calcineurin-inhibitor related nephrotoxicity- reversibility in paediatric liver transplant recipients. |
2001 |
Transplantation |
pmid:11544444
|
Murase N et al. |
Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. |
1993 |
Transplantation |
pmid:7682735
|
Gruessner RW et al. |
Mycophenolate mofetil in pancreas transplantation. |
1998 |
Transplantation |
pmid:9721799
|
Emond JC et al. |
Improved results of living-related liver transplantation with routine application in a pediatric program. |
1993 |
Transplantation |
pmid:7682738
|
Terakura M et al. |
Lymphoid/nonlymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow. |
1998 |
Transplantation |
pmid:9721804
|
Kai N et al. |
Prevention of insulitis and diabetes in nonobese diabetic mice by administration of FK506. |
1993 |
Transplantation |
pmid:7682740
|
Dean PG et al. |
Kidney transplant histology after one year of continuous therapy with sirolimus compared with tacrolimus. |
2008 |
Transplantation |
pmid:18431244
|
Sulanc E et al. |
New-onset diabetes after kidney transplantation: an application of 2003 International Guidelines. |
2005 |
Transplantation |
pmid:16249743
|
Ochiai T et al. |
Optimal serum trough levels of FK506 in renal allotransplantation of the beagle dog. |
1989 |
Transplantation |
pmid:2474208
|
Shoji T et al. |
Operational tolerance to class I disparate lungs can be induced despite pretransplant immunization with class I allopeptides. |
2007 |
Transplantation |
pmid:18091523
|
Ochiai T et al. |
Effects of combination treatment with FK506 and cyclosporine on survival time and vascular changes in renal-allograft-recipient dogs. |
1989 |
Transplantation |
pmid:2474209
|
Woodle ES et al. |
Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies. |
1996 |
Transplantation |
pmid:8878382
|
Jacobson PA et al. |
Novel polymorphisms associated with tacrolimus trough concentrations: results from a multicenter kidney transplant consortium. |
2011 |
Transplantation |
pmid:21206424
|
Kershner RP and Fitzsimmons WE |
Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. |
1996 |
Transplantation |
pmid:8878385
|
Nolan TJ and Schad GA |
Tacrolimus allows autoinfective development of the parasitic nematode Strongyloides stercoralis. |
1996 |
Transplantation |
pmid:8878405
|
McLaren A |
Tacrolimus pharmacogenetics: bringing the laboratory into the clinic. |
2003 |
Transplantation |
pmid:14705621
|
Roberts CA et al. |
Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant. |
2002 |
Transplantation |
pmid:12364862
|
Vincenti F et al. |
A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. |
2002 |
Transplantation |
pmid:11907427
|
Nguyen L et al. |
Conversion from tacrolimus/mycophenolic acid to tacrolimus/leflunomide to treat cutaneous warts in a series of four pediatric renal allograft recipients. |
2012 |
Transplantation |
pmid:22960763
|
Vafadari R et al. |
Pharmacodynamic analysis of tofacitinib and basiliximab in kidney allograft recipients. |
2012 |
Transplantation |
pmid:22960764
|
Opelz G and Döhler B |
Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation. |
2009 |
Transplantation |
pmid:19300179
|
Rostambeigi N et al. |
Unique cellular and mitochondrial defects mediate FK506-induced islet β-cell dysfunction. |
2011 |
Transplantation |
pmid:21200364
|
Mikhalski D et al. |
Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression. |
2008 |
Transplantation |
pmid:18401260
|
Jordan ML et al. |
Tacrolimus rescue therapy for renal allograft rejection--five-year experience. |
1997 |
Transplantation |
pmid:9020321
|
Thomas PG et al. |
Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation. |
2007 |
Transplantation |
pmid:17565326
|
Hu H et al. |
Effect of immunosuppressants on T-cell subsets observed in vivo using carboxy-fluorescein diacetate succinimidyl ester labeling. |
2003 |
Transplantation |
pmid:12698107
|
Ciancio G et al. |
A randomized pilot study of donor stem cell infusion in living-related kidney transplant recipients receiving alemtuzumab. |
2013 |
Transplantation |
pmid:23903014
|
Hughes JR et al. |
Blood levels of TGFbeta1 in liver transplant recipients receiving either tacrolimus or micro-emulsified cyclosporine. |
1999 |
Transplantation |
pmid:10480422
|
Uchikoshi F et al. |
Restoration of immune abnormalities in diabetic BB rats after pancreas transplantation. I. Macrochimerism of donor-graft-derived RT6+ T cells responsible for restoration of immune responsiveness and suppression of autoimmune reaction. |
1996 |
Transplantation |
pmid:8669109
|
Cacciarelli TV et al. |
Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. |
1998 |
Transplantation |
pmid:9808490
|
Nakazawa Y et al. |
Relationship between in vivo FK506 clearance and in vitro 13-demethylation activity in living-related liver transplantation. |
1998 |
Transplantation |
pmid:9808496
|
Krähenbühl S et al. |
Serious interaction between mibefradil and tacrolimus. |
1998 |
Transplantation |
pmid:9808502
|
Lerut J et al. |
Anti-CD2 monoclonal antibody and tacrolimus in adult liver transplantation. |
2005 |
Transplantation |
pmid:16314784
|
Bendahan J et al. |
The effect of administration of FK506 on delayed regeneration in flushed partially hepatectomized livers. |
1994 |
Transplantation |
pmid:7511255
|
Wissing KM et al. |
Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation. |
2006 |
Transplantation |
pmid:17006324
|
Gruessner RW et al. |
Over 500 solitary pancreas transplants in nonuremic patients with brittle diabetes mellitus. |
2008 |
Transplantation |
pmid:18192910
|
Komori K et al. |
The role of graft and host accommodation in a hamster-to-rat cardiac transplantation model. |
2008 |
Transplantation |
pmid:18192920
|
Meiser BM et al. |
Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients? |
2004 |
Transplantation |
pmid:15446320
|